<DOC>
	<DOCNO>NCT00086411</DOCNO>
	<brief_summary>The purpose study compare two different type Food Drug Administration ( FDA ) approve smoke cessation medication ( nicotine patch bupropion ) use conjunction two level counsel . It hypothesize high level counsel would high rate treatment completion high rate abstinence .</brief_summary>
	<brief_title>Comparing Smoking Treatment Programs Lighter Smokers - 1</brief_title>
	<detailed_description>The study compare minimal level counsel model high level counsel model plus one two type FDA approve smoke cessation product ( bupropion nicotine patch ) use achieve long term abstinence among light smoker . Each participant receive product blind condition mean neither participant counselor know product real placebo . The primary goal determine combination combination high low intensity counsel pharmacotherapy ( either bupropion nicotine patch ) effective light smoker . The main hypothesis high level counsel would contribute improved outcome mean counsel would associate high abstinence rate follow completion treatment long term follow-up .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Light smoker ( 615 cigarette per day Mentally physically stable , nonpregnant , light smoker ( 615 cigarette per day ) Please contact site information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>light smoker , smoke cessation treatment program</keyword>
</DOC>